Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history

» Details

Guru Trades

CWI Guru Trades in

CWI Guru Trades in

Q4 2014

CWI Guru Trades in Q4 2014

Ken Fisher 43,919 sh (New)
» More
Q1 2015

CWI Guru Trades in Q1 2015

Ken Fisher Sold Out
» More

Ratios

vs
industry
vs
history
P/E(ttm) 15.86
CWI's P/E(ttm) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CWI: 15.86 )
Ranked among companies with meaningful P/E(ttm) only.
CWI' s P/E(ttm) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 16.78
Current: 15.86
0
16.78
PE(NRI) 15.86
CWI's PE(NRI) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CWI: 15.86 )
Ranked among companies with meaningful PE(NRI) only.
CWI' s PE(NRI) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 16.78
Current: 15.86
0
16.78
P/B 1.59
CWI's P/B is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CWI: 1.59 )
Ranked among companies with meaningful P/B only.
CWI' s P/B Range Over the Past 10 Years
Min: 0  Med: 0 Max: 1.66
Current: 1.59
0
1.66

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 2.69
CWI's Dividend Yield is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CWI: 2.69 )
Ranked among companies with meaningful Dividend Yield only.
CWI' s Dividend Yield Range Over the Past 10 Years
Min: 0  Med: 0 Max: 2.74
Current: 2.69
0
2.74
Yield on cost (5-Year) 2.69
CWI's Yield on cost (5-Year) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CWI: 2.69 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
CWI' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 2.74
Current: 2.69
0
2.74

More Statistics

Short Percentage of Float0.00%
52-Week Range $27.13 - 32.99
Shares Outstanding (Mil)27,800,000.00
» More Articles for CWI

Headlines

Articles On GuruFocus.com
2017 GuruFocus Conference Early Bird Registration Will End on December 15 Dec 06 2016 
Agilent Technologies Raises Dividend 15% Dec 06 2016 
Rising Rates Meet Nesting Urges Dec 06 2016 
Can Zest Fresh Revolutionize an Industry? Dec 06 2016 
Microsoft’s Downside Dec 06 2016 
24 Questions With Value Investor Jacob Taylor of the UC Davis Graduate School of Management Dec 06 2016 
Barnes & Noble Education Reports Sales Slump Dec 06 2016 
Nihon Kagaku Sangyo Looks Undervalued Dec 06 2016 
Why Palo Alto Networks Is the Best Cybersecurity Play Dec 06 2016 
AbbVie, Johns Hopkins Unite for Cancer Research Dec 06 2016 

More From Other Websites
Allergan Generics Has Strengthened Teva’s Research Pipeline Sep 30 2016
Teva Is Well Placed to Dominate the European Generics Market Sep 28 2016
Teva’s Generic Value Chain Differentiates It from Its Peers Sep 27 2016
Teva Pharmaceutical Expected to See Strong Revenue Growth in 2016 Aug 23 2016
7 ETFs for a Lower Return Outlook Jul 26 2016
Quality Works For This Emerging Markets ETF May 09 2016
Teva: Developments in the Migraine Prevention Segment Apr 06 2016
Bendeka: How Teva Plans to Safeguard Oncology Revenues Apr 01 2016
The Zacks Analyst Blog Highlights: Vanguard Total World Stock ETF, iShares MSCI ACWI ETF, SPDR MSCI... Mar 03 2016
Build a Global Diversified Portfolio with These ETFs Mar 02 2016
Is it time for U.S. investors to look abroad? Feb 23 2016
4 Global ETFs to Outperform in Q1 Feb 05 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK